FIELD: pharmaceuticals.
SUBSTANCE: invention relates to steroid compounds (shown in the claims). The invention relates to a pharmaceutical composition for positive allosteric modulation of NDMA receptor activity, containing an effective amount of a compound or a pharmaceutically acceptable salt thereof according to the invention and a pharmaceutically acceptable carrier. The invention also relates to a method of treating a CNS disease mediated by positive allosteric modulation of NDMA receptor activity in a subject in need of such treatment, comprising administering an effective amount of a compound or a pharmaceutically acceptable salt thereof of the invention or a pharmaceutical composition based on the compound.
EFFECT: obtaining steroid compounds and their pharmaceutically acceptable salts that act as positive allosteric modulators (PAM) of NMDA and potentiate the function of the NMDA receptor.
37 cl, 2 tbl, 12 ex
Title | Year | Author | Number |
---|---|---|---|
NEUROACTIVE STEROIDS AND METHODS FOR USE THEREOF | 2014 |
|
RU2684103C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2014 |
|
RU2754534C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND THEIR USE | 2012 |
|
RU2808165C2 |
NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF | 2012 |
|
RU2665571C2 |
COMPOSITIONS AND METHODS OF TREATMENT OF DISEASES OF CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2810331C2 |
COMPOSITIONS AND METHODS OF THE TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM | 2018 |
|
RU2799448C2 |
COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | 2015 |
|
RU2733756C2 |
OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2742333C2 |
COMPOUNDS FOR THE TREATMENT OF CERTAIN LEUKOSIS | 2019 |
|
RU2804709C2 |
OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2744267C2 |
Authors
Dates
2023-11-24—Published
2014-03-13—Filed